From: Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study
Treatment
Complete remission (CR)
Partial remission (PR)
Stable disease (SD)
Partial disease (PD)
Velcade group (n = 66)
37(56.1%)
26(39.4%)
2(3.0%)
1(1.5%)
Without Velcade group (n = 30)
3(10%)
15(50%)
6(20%)